Spastic Cerebral Palsy
1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
LiNA MEDICALDenmark - Naerum
1 program3-Minute Walking Gait and Surface Electromyography AssessmentN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
Verona PharmaIncobotulinumtoxinA 100 UNT [Xeomin]
LiNA MEDICAL3-Minute Walking Gait and Surface Electromyography Assessment
Clinical Trials (2)
Total enrollment: 102 patients across 2 trials
INcobotulinumtoxina in ChIldren Upper and Lower Limb sPasticITy (INCIPIT)
Start: Jun 2022Est. completion: May 202530 patients
Phase 2Unknown
Time-Dynamic Analysis of Gait Variability in Children With Spastic Cerebral Palsy ( SCP-TIME )
Start: Jun 2024Est. completion: Oct 202572 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space